Cargando…

Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis

Detalles Bibliográficos
Autores principales:	D’Alessandro, Roberto, Garcia Gonzalez, Estrella, Frediani, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letter to the Editor (Case report)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053684/ https://www.ncbi.nlm.nih.gov/pubmed/33898920 http://dx.doi.org/10.1093/rap/rkab023

Ejemplares similares

Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis
por: Frieri, Marianne, et al.
Publicado: (2015)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

De novo lupus nephritis during treatment with belimumab
por: Parodis, Ioannis, et al.
Publicado: (2020)

Belimumab in Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Shrestha, Sanjeev, et al.
Publicado: (2021)

Urine proteomic insights from the belimumab in lupus nephritis trial
por: Weeding, Emma, et al.
Publicado: (2022)

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
por: Zhang, Han, et al.
Publicado: (2023)

Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
por: Ballew, Nick, et al.
Publicado: (2022)

Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis
por: Baum, Rebecca, et al.
Publicado: (2023)

Efficacy and Safety of Belimumab in Lupus Nephritis Patients: A Real-World Observational Study in China
por: Tan, Meng, et al.
Publicado: (2023)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report
por: Fontana, Francesco, et al.
Publicado: (2018)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

An update on belimumab for the treatment of lupus
por: Thanou-Stavraki, Aikaterini, et al.
Publicado: (2011)

Belimumab in systemic lupus erythematosus
por: Vilas-Boas, Andreia, et al.
Publicado: (2015)

Belimumab in Systemic Lupus Erythematosus
por: Srivastava, Ankita
Publicado: (2016)

Eculizumab as rescue therapy in severe resistant lupus nephritis
por: Pickering, Matthew C., et al.
Publicado: (2015)

Acquired Protein S Deficiency in a Patient with Lupus Nephritis
por: Meriam, Hajji, et al.
Publicado: (2019)

Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
por: Bruce, Ian N, et al.
Publicado: (2022)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
por: Zavala-Miranda, María Fernanda, et al.
Publicado: (2021)

Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus
por: Plüß, Marlene, et al.
Publicado: (2020)

Tattoo induced sarcoidosis
por: D’Alessandro, Roberto, et al.
Publicado: (2021)

Efficacy and safety of belimumab therapy for patients with lupus nephritis: A meta‐analysis and a propensity score‐matched case–control study
por: Zhang, Kai, et al.
Publicado: (2023)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

Re-biopsy in lupus nephritis: Re-biópsia em nefrite lúpica
por: Husein, Raida, et al.
Publicado: (2014)

Tubulointerstitial nephritis and uveitis syndrome post‐COVID‐19
por: Maggio, Maria Cristina, et al.
Publicado: (2023)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
por: Margiotta, Domenico Paolo Emanuele, et al.
Publicado: (2018)

Bullous systemic lupus erythematosus associated with increased activity of lupus nephritis: a case report and review of the literature
por: Żychowska, Magdalena, et al.
Publicado: (2018)

Cardiovascular risk assessment in lupus nephritis and ANCA-associated vasculitis in real-world nephrology practice
por: Tan, Hui Zhuan, et al.
Publicado: (2022)

Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
por: Kwon, Oh Chan, et al.
Publicado: (2021)

Serum tsRNA as a novel molecular diagnostic biomarker for lupus nephritis
por: Zhang, Xiaoshan, et al.
Publicado: (2022)

Comment on the Article “Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature”
por: Drosos, Alexandros A., et al.
Publicado: (2023)

Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
por: Dimelow, Richard, et al.
Publicado: (2020)

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
por: Urowitz, Murray B., et al.
Publicado: (2022)

Pharmacogenetic analysis of belimumab fails to identify robust genetic predictors of efficacy in lupus
por: St Jean, Pamela L., et al.
Publicado: (2019)

Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus
por: Miyazaki, Yusuke, et al.
Publicado: (2021)

The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review
por: Abid, Naushad, et al.
Publicado: (2023)

Posterior reversible encephalopathy syndrome with spinal cord involvement as the first presentation of lupus nephritis
por: Okhovat, Ali Asghar, et al.
Publicado: (2019)

Onset of Remission Following COVID-19 Infection in a Patient with Refractory Lupus Nephritis
por: Sathiavageesan, Subrahmanian
Publicado: (2022)

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients
por: Capdevila, O., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_slabumm80oscevuq6sgqoiasni